Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development for Global Health Biotech Investing
Amgen Submits Sotorasib Marketing Authorization Application To The European Medicines Agency Biotech Investing
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma Biotech Investing
Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 Biotech Investing
Solarvest Launches World's First Organic DHA Omega-3 Fruit Gummy Drops for Children Biotech Investing
Algernon CEO and CSO to Discuss COVID-19 Study Interim Data Results Featured on Streetsmart Live! Webcast Biotech Investing
Bristol Myers Squibb to Announce Results for Fourth Quarter 2020 on February 4, 2021 Biotech Investing
